Clinical Trial

4D-150 in Patients With Diabetic Macular Edema

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Phase 2 randomized, active-controlled, double-masked, dose-ranging trial in adults with Diabetic Macular Edema (DME).
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2023-06-26; most recent amendment 2025-09-17.
Status change: Recruiting → Active, Not Recruiting 2025-09-17
Status change: Not Yet Recruiting → Recruiting 2023-08-29
Trial Details
NCT Number NCT05930561
Lead Sponsor 4D Molecular Therapeutics
Conditions Diabetic Macular Edema, Diabetic Retinopathy
Enrollment 72 participants
Start Date 2023-08-09
Primary Completion 2029-02-28 (estimated)
Study Completion 2029-02-28 (estimated)
Updated on ClinicalTrials.gov 2025-09-22